+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05972070

Integration of Telemedicine and Home-Based Cardiac Rehabilitation Feasibility, Efficacy, and Adherence

Led by ROM Technologies, INC · Updated on 2025-07-24

500

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the feasibility, effectiveness, and patient adherence of a home-based cardiac rehabilitation program that incorporates telemedicine. It focuses on patients who have undergone coronary revascularization due to atherosclerotic coronary artery disease. The study assesses multiple aspects including quality of life, nutritional counseling, exercise capacity measured by metabolic equivalents METs, diabetes management, tobacco cessation, lipid and blood pressure control, and psychosocial support. Participants will start with an initial review and risk assessment before beginning 36 rehabilitation sessions led by a cardiac rehab specialist. These sessions include pre-session questions, surveys, vital sign measurements before, during, and after exercise, guided exercise protocols, and additional exercises performed off the device. The ROMTech PortableConnect Rehab System, a device that assists movement and monitors muscle activity and joint motion, is used as part of the exercise therapy. Throughout the study, participants will be monitored using various assessments such as the Duke Activity Status Index, Patient Health Questionnaire, Short Physical Performance Battery, and Short Form-36 at baseline and after 12 weeks. Laboratory tests are also conducted at these timepoints. The study tracks session attendance and completion to evaluate adherence. The total duration of participation is 12 weeks, concluding with an end-of-treatment evaluation of physical and psychosocial outcomes.

CONDITIONS

Brief Title

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over the age of 18
  • NYHA Functional Class I or II
  • Recent (within 60 days) coronary artery revascularization for atherosclerotic coronary artery disease (coronary artery bypass grafting or percutaneous coronary revascularization with stent implantation)
  • Candidate for traditional center-based cardiac rehabilitation
Not Eligible

You will not qualify if you...

  • Under the age of 18
  • Adults lacking capacity to consent
  • NYHA Functional Class III or IV
  • Acute coronary syndrome
  • Systolic heart failure with left ventricular ejection fraction less than 40%
  • History of cardiac surgery for structural heart disease or heart transplant
  • Percutaneous coronary angioplasty
  • Pregnant women
  • Adults lacking capacity to consent

Research Team

L

LaToya T. King

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here